These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9265106)

  • 1. Alpha-tocopherol and Alzheimer's disease.
    Pincus MM
    N Engl J Med; 1997 Aug; 337(8):572; author reply 573. PubMed ID: 9265106
    [No Abstract]   [Full Text] [Related]  

  • 2. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.
    Sano M; Ernesto C; Thomas RG; Klauber MR; Schafer K; Grundman M; Woodbury P; Growdon J; Cotman CW; Pfeiffer E; Schneider LS; Thal LJ
    N Engl J Med; 1997 Apr; 336(17):1216-22. PubMed ID: 9110909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-tocopherol and Alzheimer's disease.
    Kilander L; Ohrvall M
    N Engl J Med; 1997 Aug; 337(8):572-3. PubMed ID: 9265107
    [No Abstract]   [Full Text] [Related]  

  • 4. Selegiline and vitamin E in Alzheimer's disease.
    Adelman A
    J Fam Pract; 1997 Aug; 45(2):98-100. PubMed ID: 9267360
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of Alzheimer's disease -- searching for a breakthrough, settling for less.
    Drachman DA; Leber P
    N Engl J Med; 1997 Apr; 336(17):1245-7. PubMed ID: 9110915
    [No Abstract]   [Full Text] [Related]  

  • 6. Rationale and design of a multicenter study of selegiline and alpha-tocopherol in the treatment of Alzheimer disease using novel clinical outcomes. Alzheimer's Disease Cooperative Study.
    Sano M; Ernesto C; Klauber MR; Schafer K; Woodbury P; Thomas R; Grundman M; Growdon J; Thal LJ
    Alzheimer Dis Assoc Disord; 1996; 10(3):132-40. PubMed ID: 8876776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study suggests antioxidants slow decline in Alzheimer's disease.
    Am J Health Syst Pharm; 1997 Jul; 54(13):1478, 1481. PubMed ID: 9217935
    [No Abstract]   [Full Text] [Related]  

  • 8. Alzheimer's disease management.
    Cummings JL
    J Clin Psychiatry; 1998; 59 Suppl 13():4-5. PubMed ID: 9771824
    [No Abstract]   [Full Text] [Related]  

  • 9. Vitamin E and Alzheimer disease: the basis for additional clinical trials.
    Grundman M
    Am J Clin Nutr; 2000 Feb; 71(2):630S-636S. PubMed ID: 10681271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the treatment of Alzheimer's disease.
    Schneider LS
    Aging (Milano); 1998 Apr; 10(2):156-7. PubMed ID: 9666210
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug treatment for Alzheimer's disease.
    Tom T; Cummings JL
    West J Med; 1998 Apr; 168(4):264. PubMed ID: 9584667
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of longitudinal data in an Alzheimer's disease clinical trial.
    Thomas RG; Berg JD; Sano M; Thal L
    Stat Med; 2000 Jun 15-30; 19(11-12):1433-40. PubMed ID: 10844708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognosis in Alzheimer's disease].
    Kitamura S
    Nihon Rinsho; 2004 Jan; 62 Suppl():81-5. PubMed ID: 15011325
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical trials of neuroprotection in Parkinson's disease: long-term selegiline and alpha-tocopherol treatment.
    LeWitt PA
    J Neural Transm Suppl; 1994; 43():171-81. PubMed ID: 7884399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidants and Alzheimer's disease: time to stop feeding vitamin E to dementia patients?
    Ames D; Ritchie C
    Int Psychogeriatr; 2007 Feb; 19(1):1-8. PubMed ID: 17310512
    [No Abstract]   [Full Text] [Related]  

  • 16. Noncholinergic treatment options for Alzheimer's disease.
    Sano M
    J Clin Psychiatry; 2003; 64 Suppl 9():23-8. PubMed ID: 12934971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic treatment of Alzheimer's disease: an update.
    DeLaGarza VW
    Am Fam Physician; 2003 Oct; 68(7):1365-72. PubMed ID: 14567491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease.
    Ahlskog JE; Uitti RJ; Low PA; Tyce GM; Nickander KK; Petersen RC; Kokmen E
    Mov Disord; 1995 Sep; 10(5):566-73. PubMed ID: 8552107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Selegiline in the treatment of Alzheimer's disease].
    Obenberger J; Roth J
    Cas Lek Cesk; 1995 Jun; 134(12):388-90. PubMed ID: 7553744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Jumex in the treatment of Alzheimer's disease].
    Zarajczyk M
    Neurol Neurochir Pol; 1999; 33 Suppl 1():73-5. PubMed ID: 10404523
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.